In vivo role of IL-6 on the viral load and on immunological abnormalities of HIV-infected patients

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 1, 1996, Pages 59-68

  Marfaing Koka, Anne ^a   Aubin, Jean Thierry ^b   Grangeot Keros, Liliane ^a,c   Portier, Alain ^a   Benattar, Clarisse ^c   Merrien, Dominique ^a,d   Agut, Henri ^b   Aucouturier, Pierre ^e   Autran, Brigitte ^b   Wijdenes, John ^f   Galanaud, Pierre ^a   Emilie, Dominique ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HÔPITAL ANTOINE BÉCLÈRE   (France)

^d HÔTEL DIEU   (France)

^e CNRS URA 1172   (France)

^f Diaclone   (France)

Author keywords

Acute phase reaction; B lymphocyte; Cytokine; HIV; Immunoglobulins; Interleukin 6

Indexed keywords

INTERLEUKIN 6;

ARTICLE; BODY BURDEN; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; VIREMIA; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 1542534801     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199601010-00008     Document Type: Article

References (56)

1. Birx DL, Redfield RR, Tencer K, Fowler A, Burke DS, Tosato G. Induction of interleukin-6 during human immunodeficiency virus infection. Blood 1990;76:2303-10.
2. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1990;144:480-4.
3. Honda M, Kitamura K, Mizutani Y, et al. Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-induced diseases. J Immunol 1990;145:4059-64.
4. Emilie D, Peuchmaur M, Maillot MC, et al. Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes. J Clin Invest 1990;86:148-59.
5. Nakajima K, Martinez-Maza O, Hirano T, et al. Induction of IL-6 (B cell stimulatory factor-2/IFN-β2) production by HIV. J Immunol 1989;142:531-6.
6. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, Walker SM. Exogenous tat protein activates human endothelial cells. Blood 1993;82:2774-80.
7. Scala G, Ruocco MR, Ambrosino C, et al. The expression of the interleukin-6 gene is induced by the human immunodeficiency virus tat protein. J Exp Med 1994;179:961-71.
8. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor a by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-8.
9. Schnittman SM, Singer KH, Greenhouse JJ, Stanley SK, Whichard LP, Haynes BF, Fauci AS. Thymic microenvironment induces HIV expression. Physiologic secretion of IL-6 by thymic epithelial cells up-regulates virus expression in chronically infected cells. J Immunol 1991;147:2553-8.
10. Rieckmann P, Poli G, Kehrl JH, Fauci AS. Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1. J Exp Med 1991;173:1-5.
11. Kishimoto T. The biology of interleukin 6. Blood 1989;74:1-10.
12. Emilie D, Fior R, Llorente L, et al. Cytokines from lymphoid organs of HIV-infected patients: production and role in the immune disequilibrium of the disease and in the development of B lymphomas. Immunol Rev 1994;140:5-34.
13. Emilie D, Coumbaras J, Raphael M, et al. Interleukin-6 production in high grade B lymphomas: correlation with the presence of malignant immunoblasts in acquired immunodeficiency syndrome and in human immunodeficiency virus-seronegative patients. Blood 1992;80:498-504.
14. Emilie D, Wijdenes J, Gisselbrecht C, et al. Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood 1994;84:2472-9.
15. Coombs RW, Collier AC, Allain JP, Nikora B, Leuther M, Gjerset GF, Corey L. Plasma viremia in human immunodeficiency virus infection. N Engl J Med 1989;321:1626-31.
16. Rouzioux C, Puel J, Agut H, et al. Comparative assessment of quantitative HIV viremia assays. AIDS 1992;6:373-7.
17. Laure F, Rouzioux C, Veber F, et al. Detection of HIV-1 DNA in infants and children by means of polymerase chain reaction. Lancet 1988;2:538-41.
18. Defer C, Agut H, Carbarg-Chenon D, et al. Multicentric control of polymerase chain reaction for detection of HIV DNA. AIDS 1992;6:659-63.
19. Dandliker WB, Feigen GA. Quantification of the antigen-antibody reaction by polarization of fluorescence. Biochem Biophys Res Commun 1961;5:299-304.
20. Aucouturier P, Danon F, Daveau M, Guillou B, Sabbah A, Besson J, Preud'homme JL. Measurement of serum IgG4 levels by a competitive immunoenzymatic assay with monoclonal antibodies. J Immunol Methods 1984;74:151-62.
21. Ganter U, Arcone R, Toniatti C, Morrone G, Ciliberto G. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBO J 1989;8:3773-9.
22. Poli V, Cortese R. Interleukin-6 induces a liver-specific nuclear protein that binds to the promoter of acute-phase genes. Proc Natl Acad Sci USA 1989;86:8202-6.
23. Gauldie J, Northemann W, Fey GH. IL-6 functions as an exocrine hormone in inflammation: hepatocytes undergoing acute phase responses require exogeneous IL-6. J Immunol 1990;144:3804-8.
24. Mackiewicz A, Speroff T, Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol 1991;146:3032-7.
25. Pantaleo G, Graziosi C, Demarest J, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
26. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K, Haase AT, Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-62.
27. Devergne O, Peuchmaur M, Crevon MC, Trapani JA, Maillot MC, Galanaud P, Emilie D. Activation of cytotoxic cells in hyperplastic lymph nodes from HIV-infeeted patients. AIDS 1991;5:1071-9.
28. Hadida F, Parrot A, Kieni MP, Sadat-Sowti B, Mayaud C, Debre P, Autran B. Carboxy-terminal and central regions of human immunodeficiency virus-1 nef recognized by cytotoxic T lymphocytes from lymphoid organs. J Clin Invest 1992;89:53-60.
29. Nishanian P, Hofmann B, Wang Y, Jackson AL, Detels R, Fahey JL. Serum soluble CD8 molecule is a marker of CD8 T-cell activation in HIV-1 disease. AIDS 1991;5:805-12.
30. Agostini C, Pizzolo G, Zambello R, et al. Shedding of the soluble form of the CD8 complex by CD8 + /HLA-DR + cells in HIV-1-infected patients. AIDS 1991;5:813-9.
31. Galli M, Ridolfo AL, Balotta C, et al. Soluble interleukin-2 receptor decrease in the sera of HIV-infected patients treated with zidovudine. AIDS 1991;5:1231-5.
32. Bass HZ, Yamashita N, Clement LT. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation: Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8 + precursor subpopulations. J Immunol 1993;151:2895-903.
33. Oldenburg HSA, Rogy MA, Lazarus DD, et al. Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6. Eur J Immunol 1993;23:1889-94.
34. Fattori E, Cappelletti M, Costa P, et al. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med 1994;180:1243-50.
35. Kopf M, Baumann H, Freer G, et al. Impaired immune and acute phase responses in interleukin-6-deficient mice. Nature 1994;368:339-42.
36. Guenter P, Muurahainen N, Simons G, Kosok A, Cohan GR, Rudenstein R, Turner JL. Relationships among nutritional status, disease progression, and survival in HIV infection. J AIDS 1993;6:1130-8.
37. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cachexia. J Clin Invest 1992;89:1681-4.
38. Strassmann G, Jacob CO, Evans R, Beall D, Fong M. Mechanisms of experimental cancer cachexia: interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. J Immunol 1992;148:3674-8.
39. Grunfeld C, Feingold KR. Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992;327:329-37.
40. Coodley GO, Loveless MO, Merill TM. The HIV wasting syndrome: a review. J AIDS 1994;7:681-94.
41. Spiegelman BM, Hotamisligil GS. Through thick and thin: wasting, obesity, and TNFα. Cell 1993;73:625-7.
42. Strassmann G, Masui Y, Chizzonite R, Fong M. Mechanisms of experimental cachexia. Local involvement of IL-1 in colon-26 tumor. J Immunol 1993;150:2341-5.
43. Helle M, Boeije L, Aarden LA. IL-6 is an intermediate in IL-1-induced thymocyte proliferation. J Immunol 1989;142:4335-8.
44. Sironi M, Breviario F, Proserpio P, et al. IL-1 stimulates IL-6 production in endothelial cells. J Immunol 1989;142:549-53.
45. Elias J, Lentz V. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA. J Immunol 1990;145:161-6.
46. Loppnow H, Libby P. Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. J Clin Invest 1990;85:731-8.
47. Libert C, Brouckaert P, Shaw A, Fiers W. Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice. Eur J Immunol 1990;20:691-4.
48. Roldan E, Rodriguez C, Navas G, Parra C, Brieva JA. Cytokine network regulating terminal maturation of human bone marrow B cells capable of spontaneous and high rate Ig secretion in vitro. J Immunol 1992;149:2367-71.
49. Aloisi F, Care A, Borsellino G, et al. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α. J Immunol 1992;149:2358-66.
50. Emilie D, Crevon MC, Auffredou MT, Galanaud P. Glucocorticosteroid-dependent synergy between interleukin-1 and interleukin-6 for human B lymphocyte differentiation. Eur J Immunol 1988;18:2043-7.
51. Renauld JC, Vink A, Van Snick J. Accessory signals in murine cytolytic T cell responses: dual requirement for IL-1 and IL-6. J Immunol 1989;143:1894-8.
52. Amadori A, Zamarchi R, Veronese ML, et al. B cell activation during HIV-1 infection: cell-to-cell interactions and cytokine requirements. J Immunol 1991;146:57-62.
53. Fujihashi K, McGhee JR, Lue C, et al. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest 1991;88:248-52.
54. Kono Y, Beagley KW, Fujihashi K, et al. Cytokine regulation of localized inflammation: induction of activated B cells and IL-6-mediated polyclonal IgG and IgA synthesis in inflamed human gingiva. J Immunol 1991;146:1812-21.
55. Rautonen J, Rautonen N, Martin N, Philip R, Wara DW. Serum interleukin-6 concentrations are elevated and associated with elevated tumor necrosis factor-α and immunoglobulin G and A concentrations in children with HIV infection. AIDS 1991;5:1319-25.
56. Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 1994;264:561-3.